PortViewPortView
Integra LifeSciences logo

Integra LifeSciences (IART) Stock Analysis

NASDAQHealthcareMedical - Devices

$16.94+1.91%
1-year price historyRange $8.90 – $19.85
52-week range$16.94
$8.70$20.49

What Integra LifeSciences does

Integra LifeSciences Holdings Corporation is a medical technology company focused on the creation, production, and global distribution of advanced surgical implants and instruments. These products are utilized across various medical fields, including neurosurgery, limb reconstruction, and general surgical procedures. The company operates through two primary business segments: Codman Specialty Surgical and Tissue Technologies. The Codman Specialty Surgical division offers a comprehensive range of neurosurgical and neuro-critical care products. This includes specialized equipment for tissue ablation, dural repair solutions, cerebral spinal fluid management systems, intracranial monitoring tools, and cranial stabilization devices. Additionally, this segment provides surgical headlamps, various instrumentation, and supports these offerings with asset management software, technical assistance, and after-market services. Integra also supplies an extensive catalog of approximately 40,000 surgical instrument designs, along with a wide selection of surgical and lighting products. Its clientele spans hospitals, surgical centers, and extends to dental, podiatry, and veterinary practices. The Tissue Technologies segment specializes in innovative regenerative technology products for the treatment of both acute and chronic wounds. It further provides surgical tissue repair solutions for a multitude of applications, such as hernia repair, peripheral nerve protection and regeneration, and tendon reconstruction. This encompasses a broad array of offerings for skin and wound repair, plastic and reconstructive surgery products, bone grafting materials, and specialized nerve and tendon repair products. Integra LifeSciences distributes its diverse product portfolio internationally, reaching markets throughout the United States, Europe, Asia Pacific, and other global regions. Distribution is managed directly through its dedicated sales forces and various other channels, serving a wide array of healthcare entities including hospitals, integrated health networks, group purchasing organizations, individual clinicians, surgery centers, and other healthcare providers. Founded in 1989, Integra LifeSciences Holdings Corporation is headquartered in Princeton, New Jersey.

Key metrics

Market cap
$1.32B
P/E (TTM)
7.18
EPS (TTM)
$2.36
Beta
1.21
Dividend yield
0.00%
Revenue / share
$21.08
50-day avg
$17.88
200-day avg
$13.71
52-week high
$20.49
52-week low
$8.70
CEO
Stuart Essig

ETFs linked to IART

Broad-market and Healthcare sector ETFs an investor holding Integra LifeSciences is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how IART fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze IART in PortView →

Similar companies

Frequently asked questions

What is the ticker symbol for Integra LifeSciences?
Integra LifeSciences trades under the ticker IART on NASDAQ.
Which exchange is IART listed on?
IART is listed on NASDAQ.
What sector does Integra LifeSciences operate in?
Integra LifeSciences is classified in the Healthcare sector (Medical - Devices industry).
How can PortView help analyze IART in a portfolio?
PortView shows IART's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.